Caxton Associates (New York)’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,246
| Closed | -$90.4K | – | 403 |
|
|
2023
Q2 | $90.4K | Sell |
2,246
-1,973
| -47% | -$79.4K | 0.01% | 454 |
|
|
2023
Q1 | $306K | Sell |
4,219
-3,768
| -47% | -$273K | 0.05% | 349 |
|
|
2022
Q4 | $655K | Buy |
7,987
+106
| +1% | +$8.69K | 0.04% | 173 |
|
|
2022
Q3 | $745K | Buy |
7,881
+7,383
| +1,483% | +$698K | 0.1% | 156 |
|
|
2022
Q2 | $97K | Buy |
+498
| New | +$97K | 0.01% | 498 |
|